News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Announcement Of A Firm Intention By CFR Pharmaceuticals To Acquire 100% Of The Issued Share Capital Of Adcock Ingram By Way Of A Scheme Of Arrangement


11/18/2013 9:35:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTIAGO, Chile, Nov. 15, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialities and prescription medicines, today issued a firm intention announcement ("FIA") to acquire 100% of the issued share capital (excluding the Bophelo Scheme Shares and the Treasury Shares) of Adcock Ingram Holdings Limited ("Adcock Ingram"), the South Africa pharmaceutical company, for a total consideration of approximately US$1.26 billion ("Acquisition"). Terms not defined herein have the meaning attributed to them in the FIA.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES